NAP1L1 has been reported to be highly expressed in several types of human malignancies, including colorectal cancer, hepatocellular cancer, lung adenocarcinoma, and renal cancer [5–8]; however, its expression level in OC is not yet clear. Here, NAP1L1 is linked to hepatocellular carcinoma.